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Abstract
Despite the need for HIV-positive children to adhere effectively to antiretroviral treatment (ART), a guiding
theory for pediatric ART in resource-limited settings is still missing. Understanding factors that influence pe-
diatric ART adherence is critical to developing adequate strategies. In-depth qualitative interviews were un-
dertaken in Kinshasa, Democratic Republic of the Congo, with 20 sets of HIV disclosed and nondisclosed
children along with respective caregivers to better characterize barriers, facilitators, and adherence experiences
in children taking ART. Commonly cited barriers included lack of food or nutritional support, lack of assistance
or supervision for children, lack of assistance for caregivers, and being unable to remember to take medicines on
a consistent basis. Facilitators included having a strong caregiver–child relationship and support system along
with strategies for maintaining adherence. Similar themes arose within the child–caregiver sets, but were often
characterized differently between the two. Children who were aware of their HIV status displayed fewer
instances of frustration and conflict concerning taking medicines and within the child–caregiver relationship.
Continued study on pediatric ART adherence should account for differing perspectives of children and care-
givers, as well as between status disclosed and nondisclosed children. Areas of future intervention should focus
on child–caregiver relationships, disclosure of HIV status, and available nutritional and psychosocial support for
children and their caregivers.
Introduction
In 2008 over 2 million children worldwide were livingwith HIV/AIDS, of whom 90% lived in sub-Saharan Afri-
ca.1 Pediatric antiretroviral therapy (ART), including early
treatment of HIV-positive infants, has been shown to improve
clinical outcomes.1,2
Despite improving availability of ART, adherence remains
a problem and ART regimens may be complicated for chil-
dren in resource limited settings. Accurately gauging ART
adherence in these children is extremely important because
maintaining high rates of adherence is required for successful
treatment of HIV. Estimates of 90% adherence or greater are
recommended for optimal virologic suppression and to min-
imize failure rates.3–6 An exact rate of adherence to pediatric
ART regimens necessary to reduce risk of adverse outcomes is
not firmly established as resistance to ART may depend on
regimen type and HIV subtype rates. However, poor adher-
ence to ART has been associated with viral resistance, op-
portunistic infections and ultimately failure of therapy.3,6–8
There continues to be a lack of guiding theory in pediatric
ART adherence research in resource-limited settings and few
reliable predictors of nonadherence have been established.9–12
There is little consensus on what factors contribute most to
pediatric ART adherence in resource limited settings, which
may be a more complex issue than with adult counter-
parts.12,13 While numerous studies in adults have been un-
dertaken to better understand adherence in these settings,
studies in children are still sparse. To date, quantitative
studies in children looking at factors predictive of non-
adherence vary in both their methods and results. Definitions
for what is meant by ‘‘adherent,’’ factors measured, and
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analyses vary widely among published studies, making it
difficult to compare across studies to draw conclusions.12
Qualitative research is thus needed in resource limited set-
tings. Qualitative research methods may shed light on factors
that influence pediatric adherence and further represent an
alternative to evaluate pediatric ART adherence levels. It can
be used to inform the development of more valid, culturally
appropriate adherence measures and a contextual adherence
theory.11,12
Program data collected using standard questionnaires at
the Kalembe Lembe Pediatric HIV Clinic in Kinshasa, De-
mocratic Republic of the Congo (DRC) revealed that moe than
99% of respondents reported perfect adherence to pediatric
ART regimens within the preceding 2 days, along with zero
days of missed treatment within the last month (F. Behets,
unpublished data). This demonstrates the suspected inability
to accurately capture adherence rates and experiences using
survey methods. These numbers are well above expected
adherence rates among children in similar settings where
prior reviews have shown average adherence rates ranging
from 50% to 80%.12,14,15
The objectives of our study were to qualitatively assess
barriers and facilitators of ART adherence and the reported
effects of child–caregiver relationships, psychosocial support
structures, perceptions of living with HIV and of the concept
of being ‘‘adherent’’ to medication. We aimed to increase our
understanding of how and why the above effect ART adher-
ence and to characterize interaction among complex social
dynamics and living situations, overall guiding further de-
velopment of adherence theory and future studies. As a sec-
ondary objective we assessed specific adherence experiences
among children and compared adult caregiver with child
perceptions of adherence to ART.
Methods
Overview
In-depth semistructured interviews were conducted with
children 8–17 years old and with their corresponding primary
caregivers. The research was approved by the Institutional
Review Board at the University of North Carolina at Chapel
Hill in the United States and the Kinshasa School of Public
Health Ethics Review Committee in the DRC. Informed con-
sent, parental consent, and informed assent were obtained as
appropriate.
Setting and recruitment
All children were recruited at the HIV clinic of the Kalembe
Lembe Public Pediatric Hospital (KLL) in Kinshasa, DRC.
Nine hundred fifteen HIV-positive children had been enrolled
at this clinic as of September 1, 2010. A total of 20 sets of
children and their respective primary caregivers were pur-
posively recruited from the clinic cohort for this study by KLL
HIV clinic staff if they were between 8 and 17 years of age,
HIV seropositive, on ART for at least 6 months, and had a
history of perceived poor adherence noted in their medical
record or if their health care provider suspected poor adher-
ence. In addition, we recruited one child who had perceived
good adherence along with her caregiver, to explore infor-
mation about factors that facilitated adherence. The primary
caregiver, defined as the adult who primarily serves to assist
the child with taking ART, was recruited along with each
child. This relationship was assessed by study recruiters
during initial recruitment scripts. If this was not the person
who accompanied the child to the clinic, an attempt was made
to contact and arrange follow-up with this person. Subjects
were excluded if the child or caregiver was unwilling or un-
able to be interviewed alone or if the participants were per-
sonally known to an interviewer.
We recruited children who were both aware and unaware
of their HIV infection, the status of which is routinely noted in
their medical chart. Therefore ‘‘HIV/AIDS’’ or ‘‘ART’’ was not
mentioned during initial recruitment. All caregiver interviews
preceded child interviews and it was at that time the child’s
disclosure status was confirmed. Children who were aware of
their status were fully informed of the study objectives re-
garding HIV/AIDS and ART, whereas those who were un-
aware were informed that this was a general study regarding
medication adherence.
Each participant was compensated with an equivalent of $5
USD for their time ($10 for caregiver/child sets) and was
provided with snack and drink during their interview session.
Study design and data collection
A total of 40 interviews were conducted exploring the ex-
periences of the study participants in dealing with ART reg-
imens. We selected this number because previous studies on
ART adherence had reached a saturation of themes inter-
viewing from 20 to 50 participants and our taking into account
budget and time constraints.14,16–18
Three separate interview scripts, consisting of 14 to 22
questions, were developed and administered to adults, chil-
dren aware of their HIV infection, and children uninformed of
their HIV infection. Scripts for disclosed and nondisclosed
children were similar with several questions relating specifi-
cally to HIV being omitted from the nondisclosed status
script. The interviews began with structured questions that
asked about individual demographics and the relationship
between child and caregiver. We then used open-ended
questions with a list of probes to explore general themes with
adult caregivers about overall attitudes toward ART regi-
mens, perceived benefits or liabilities of ART, health beliefs on
ART and on HIV, what ‘‘good adherence’’ meant to them,
perceived barriers in carrying out regimens as prescribed, and
facilitators which aid ART adherence. Throughout the inter-
views the child–caregiver relationship was characterized in
greater detail. These questions were followed by an assess-
ment of the child’s specific adherence experiences. For in-
stance, caregivers were asked, ‘‘What types of things make
taking medicine more difficult for your child?’’, and then
followed with more closed-ended probes related to how taste,
difficult schedule, stigma, or going to school or work can af-
fect adherence. We used the same kinds of open ended
questions with probes to explore similar themes and the
child–caregiver relationship with the child participants. These
included beliefs regarding ART and HIV (for disclosed chil-
dren) and perceived barriers and facilitators to good adher-
ence of their medicine. Throughout the process, we explored
specific instances of missed doses that arose.
Question sets were developed to meet study objectives
regarding adherence through a mix of deductive question
development, prior literature searches exploring themes
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regarding ART adherence, and through meetings with the
KLL HIV clinic physicians and support staff.11,12,14,19 The
semistructured nature of the interviews and multiple
question probes allowed interviewers to explore topics in
detail which were relevant to each participant, yet allowed
for additional exploration and clarification of new and
emerging issues pertinent to ART adherence.
For the assessment of adherence, both caregivers and
children were asked a series of time intervals in which they
had missed their last dose. For instance, we asked ‘‘Have you
missed a dose in the last day, 2 days, 3 days, week, month?’’
Since the primary objective did not include assessing whether
the participants were adherent or not, there was no definition
as such. Responses of the children and caregivers were com-
pared to assess for likeness between them.
Trained Congolese qualitative interviewers, fluent in Lin-
gala, conducted interviews in private rooms. Several rehearsal
interviews were performed with the clinic staff to familiarize
the interviewers with the questions and to deal with delicate
issues surrounding HIV disclosure. Further, questions were
screened for poor wording or lack of clarity that might have
occurred in translation from English to Lingala and adjusted
accordingly.
Interviews lasted 45–90 min for children and 60–120 min
for adult caregivers. All interviews were digitally recorded,
with participants’ consent, and directly translated into En-
glish during transcription. Each interview was proofread for
translation errors by a study coordinator fluent in both En-
glish and Lingala.
Analysis
Data were analyzed using qualitative content analysis to
identify themes and patterns as related to research ques-
tions.20 The translated interview scripts were entered into
Atlas.Ti v. 6.1 (Atlas.Ti Scientific Software Development,
Berlin, Germany) and line-by-line coding of each transcribed
page was undertaken. A mixture of deductive and inductive
codes were progressively developed, reviewed by other team
members, and applied to the transcripts. Codes were applied
to the transcripts in multiple iterations in order to produce a
consistent and reliable coding framework.
Deductive codes included issues with the medication reg-
imen, side effects, or medicine characteristics, issues relating
to money, issues relating to home or school life, or issues
related to stigma or the community. In addition to these
themes, a number of other factors emerged during the anal-
ysis that were captured. All codes were specifically defined
and applied to excerpts that met that definition.
The coding framework was reviewed and combined into
broader categories for a more concise presentation of results.
Ultimately each code was interpreted based on the general
accord among responses. Specific pattern comparisons in
coding were made between adults and children and between




A total of 40 interviews were completed, 20 with children
and 20 with their corresponding caregivers. One adult and
one child interview were cut-short and unable to be com-
pleted due to scheduling conflicts of the participants, yielding
18 complete sets. The characteristics of the cohort are pro-
vided in Table 1. The ages of the children ranged from 9 to17
years and from 25 to 63 years among adult caregivers. Most
children were primarily cared for by a family member other
than the biological parents (n = 17). Nine children were listed
as having both parents deceased. The nonrelative caregivers
included persons working in an orphanage (n = 2) and a
family friend (n = 1).
All children had been actively receiving care and treat-
ment at KLL for 1–5 years and had at least one follow-up visit
in the 6 months prior to their participation in this study.
The majority of ART regimens consisted of standard first line
pediatric treatment zidovudine or stavudine plus lamivu-
dine plus nevirapine or efavirenz. Seven of the children were
on alternate or second-line pediatric regimens as outlined by
the World Health Organization ART Guidelines.3 Docu-
mented instances of perceived poor adherence had been
noted by clinic staff for 19 of the children, while 1 child was
noted to have perceived good adherence. Reasons for per-
ceived poor adherence noted from the child’s medical chart
included lack of assistance in the home, instances of child
refusing to take medications, repeated missing of clinic ap-
pointments, stated mistrust in the medications, and a high
level of curiosity regarding the reason for medications.
Four of the children were living with other HIV-positive
members in their household, either their caregiver or another
child. All but one caregiver described their child’s health as
excellent or quite good, the exception noting their child’s
health as poor.
Table 1. Demographics












8 to 11 5 25.0%
12 to 15 11 55.0% Completed
education











Yes 4 20.0% State diploma 4 20.0%




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Thirteen children had not been informed of their HIV in-
fection. This reflects practices commonly observed at the KLL
Clinic and elsewhere in sub-Saharan Africa.14,21 In three in-
stances the caregiver was unsure if the child was informed or
not, but either suspected that the child knew or that the child
was highly suspicious without having been officially in-
formed. The route of HIV acquisition was unknown in most
children, however it is presumed to be perinatal in most
instances.
A number of themes emerged from a majority of study
participants relating to adherence. Selected quotes, felt to be
an adequate representation of responses, regarding these
themes are given in Table 2.
Barriers associated with adherence
Most prominent among barriers to adherence was the idea
of being frustrated or ‘‘fed up’’ with the medication regimen.
Often the children compared themselves to peers and they
noted the fact that other children are not constrained by such
medicine regimens. This theme arose much more frequently
in the 16 children who were unaware of their HIV infection
and their respective caregivers with 36 instances compared
with only 3 instances among the 4 disclosed children. Frus-
tration occurred regardless of age but was more frequently
cited in older adolescents.
Lack of food in the home was another significant and
commonly cited barrier by the children (n = 11; 55%). Many
children described discomfort, often a ‘burning’ sensation or
feeling ‘‘dizzy, lightheaded,’’ after taking ART. These sensa-
tions were described as being alleviated through consump-
tion of food with taking medicine. However, there was not
always food available when ART doses were scheduled. 25%
(n = 5) of children stated they would flatly refuse to take their
medicine if no food was available.
Lack of assistance also played a major role in poor adher-
ence. It was apparent that some form of adult supervision,
even with the adolescents, was necessary for optimal levels of
adherence. Given how frustrated many of these children be-
came regarding their regimens, without strong psychosocial
support or reminders of the continued importance of medi-
cation from caregivers, children would often admit to skip-
ping doses when they could get away with it. Caregivers
acknowledged that when they were not around, their child
was more likely to miss a dose. A complicating factor in this
scenario was that most caregivers had no other adults to assist
them with administering medicine for their child. Often due
to issues with stigma, caregivers were fearful of disclosing
the child’s HIV status to other family members or friends
and were unwilling or unable to recruit others for additional
assistance.
The act of forgetting was also mentioned by both children
and adult caregivers and tied heavily into lack of adult as-
sistance. It was described as ‘‘easy’’ or ‘‘common’’ to forget
taking medications by the children. Children were often
preoccupied with their social lives and recreational activities.
Though taking medication was, on their own admission, a
priority for most children, unless the adult was vigilant or
strategies for remembering were in place, forgetting doses
appeared to occur on a frequent and haphazard basis.
A number of other adherence barriers were cited multiple
times by both children and caregivers within this study,
though were only mentioned in one or two sets while the
above mentioned barriers were more pervasive throughout
the interviews. Adherence barriers that were mentioned re-
peatedly by a few sets included difficulties with taking
medicine in secret, belief they are healthy and not under-
standing the rationale for continued medication use, and
simply lack of motivation and not understanding the purpose
of medicines in the nondisclosed group.
Many children described issues with the characteristics of
the medicine itself (bad taste, large quantity, and dosing fre-
quency) as well as side effects, such as irritated or upset
stomach and fatigue, as things they disliked about the medi-
cine. However these did not seem to play roles as major det-
riments to ART adherence. Typically the children accepted
these factors and addressed them through taking the medi-
cine with food or sweets. Money for transport or food was
twice cited as a barrier from a number of caregivers. Issues
related specifically to school or home life did not appear to
play major roles either, as the children could schedule doses
for before or after school, and developed strategies for taking
medicines in private while at home.
Adult caregivers and children were overall in agreement
regarding barriers to ART adherence as the themes coded in
adult interviews frequently mirrored what arose during their
child’s interview. For instance, if we saw one caregiver re-
marking how his or her child refused taking ART due to lack
of food, typically we heard the child remarking about this
same issue from their perspective.
Facilitators associated with adherence
Adult caregivers and children were asked how their med-
ication regimens could be easier to adhere to or, when specific
barriers arose during the interview sessions, we prompted
them for potential solutions to these issues.
Having assistance or increased psychosocial support was
one of the most commonly cited reasons for good adherence, a
theme which arose in 26 children (n = 15) and caregiver in-
terviews (n = 11). This mirrors the frequency with which lack
of assistance was cited as a barrier to adherence. Support or
assistance was described in many forms. Often it was cited by
the child as coming from the caregiver themselves. Having a
vigilant caregiver was helpful in reducing instances of for-
getting and overcome issues with frustration. Assistance from
the HIV clinic was also noted as significant in terms of the free
provision of medications and the psychosocial support of-
fered to children and caregivers.
Assistance also came in the form of other family members.
When there were two or more caregivers who assisted the
child in taking medications, there were less conflict or child–
caregiver relationship issues coded. Assistance was not cited
as coming from the community or from those outside the
family, other than the KLL clinic staff. In 8 caregiver inter-
views and 6 child interviews, participants cited religion or
faith as helping to provide motivation toward keeping the
child or themselves respectively adherent to medications.
Another 15 caregivers and children directly cited the quality
of medical care, counseling from clinic, and the availability of
support groups at the clinic as helping to remain motivated in
taking medications.
The belief itself that the medication was helping also served
as a strong facilitator to adherence. Often caregivers and
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children would cite instances of impressively improved
health since beginning ART, even nondisclosed children.
Some caregivers expressed a high degree of understanding
about the importance of maintaining good adherence to ART
and consequences of poor adherence. This level of under-
standing served to increase vigilance toward adherence.
In all 18 complete interview sets, having a routine or
strategy were noted to be important in maintaining good
adherence. Both adults and children found it helpful to set
specific times of day as medication times, for instance at 08:00
and 20:00 hours. Though they were not always able to take
doses right on the mark, after a while these times of day be-
came associated with taking medications and provided an
internal cue to do so. Keeping medicines consistently within
the same spot was also helpful, as passing this spot also could
cue a reminder toward taking medication. For instance, this
could be in a special place in the cupboard, a small box on the
child’s nightstand, or any place frequently encountered at
these times of day. However, it was important for this to be
placed where other family members or friends would not
disturb or discover the medications.
Several specific strategies were mentioned during the in-
terviews and came in two forms. One involved strategies for
being reminded to take medications. To remind themselves to
take medicines, caregivers would set phone or clock alarms at
appropriate times. Keeping logs as a record of completed
doses was also mentioned. These logs could be kept by the
bedside of the caregiver and checked every night.
Other strategies related to ways in which caregivers would
motivate or convince the children to remain vigilant toward
taking their mediation. In motivating children to take their
doses, several strategies were used by caregivers. Inducement
was not uncommon for good adherence, including small
amounts of money or gifts from the caregivers. Fear was also
commonly used with nondisclosed children. This often in-
volved some form of deception or exaggeration of the effects
of missed doses. Some caregivers felt that since they could not
reveal the true purpose of the child’s medication, scaring them
into continuing to take their medications was the only effec-
tive method available.
Shame and stigma as related to adherence
and disclosure
The shame of having to take daily medications on a regular
basis and how HIV is stigmatized in the community played a
role in maintaining good adherence. The theme of shame or
stigma most commonly arose along with cited barriers to
adherence. The children, even the younger ones, realized that
taking these medicines made them different from others and
created opportunity for stigmatization or ridicule.
Numerous instances were cited in which the children had
been teased or were repeatedly asked questions from peers or
other community members regarding their medicines. Typi-
cally these were negative experiences and often made the
children uncomfortable to recollect. Therefore, the children
were either taught by their caregiver or had taught themselves
to always take their medication in private. However, this
practice became a problem if the children were not in their
routine schedule (i.e., during travel, when relatives or friends
visited the home, or when special events and festivals took
place) and was the cause of several described instances of
missed doses. In addition, if children missed their morning
dose or did not have food at that time, they would skip the
dose rather than taking medication to school and risk being
‘‘discovered.’’
This was in part related to why caregivers felt it was nec-
essary to delay disclosure to their child—to protect them from
the effects that stigma to their disease carries. Also, caregivers
felt their child could not be trusted with information related to
the true nature of their condition and if they knew the truth it
may be inadvertently revealed to their friends, their friends’
parents, the community, and so forth. This was a great fear
expressed by some caregivers. Therefore, the common senti-
ment was that it would be better if as few individuals
knew the child’s HIV status as possible, which often included
the child.
HIV disclosure status of the child and adherence
Although only 4 of the 20 children knew they had HIV, it
was evident that these children had a different perspective
regarding their medication regimens. Overall the informed
children reported fewer barriers to adherence when com-
pared with the uninformed children.
Nondisclosure of HIV status itself served as a barrier to
adherence while disclosure frequently served as a motivating
factor. As mentioned earlier, misunderstanding the rationale
behind the medicines often served to frustrate the children
and many of them could not understand why they would
continue to take medicine if they felt healthy.
Deception and conflict were two themes that emerged
during the analysis as related to disclosure status. These ap-
peared more frequently, per interview, in the non-disclosed
group. Deception was noted in instances where there was
deception by the child about taking his or her medicine or
deception by the caregiver toward the child regarding the
medicine. Conflict was cited in instances of conflict between
the child and caregiver.
Three of the four caregivers of disclosed children directly
cited their child’s knowledge and understanding of HIV as a
motivating factor for adherence. Many unresolvable issues
nondisclosed children faced, such as rationale behind med-
ication regimens, length of treatment, and importance of
strict adherence were no longer poignant issues. These
caregivers believed their children’s adherence directly im-
proved postdisclosure. Furthermore, one caregiver used
improved adherence as their rationale for moving toward
disclosure.
Of the informed children, sentiments were similar to their
caregivers regarding disclosure. When directly asked, none
regretted knowing their status. They often reported that their
knowledge gave them ‘‘strength’’ in adherence to medications.
Understanding how and why the medications made them
healthy was an overall strong motivator to remain adherent.
Adherence experiences
Adherence was assessed at the end of each interview
session after rapport was developed between the interviewer
and interviewee and a brief script to destigmatize missed
doses was read to the participant. Responses are presented in
Table 3. Adult caregivers and children frequently mirrored
one another when speaking on barriers and facilitators to
adherence; however, this was not the case when reporting a
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direct measurement of adherence. Discrepancies were found
between the child and caregiver’s responses in most inter-
view sets. Only 6 caregiver-child (33%) sets were in agree-
ment with one another regarding the question of most
recently missed ART dose. In the 12 remaining completed
interview sets the child and caregiver responses differed. In
these instances the child typically reported a more recent
missed dose compared with the adult caregiver (n = 11). In 9
of the interview sets, the adult reported no instances of
missed doses in the prior month however only 4 of those
children agreed.
Seven participant sets reported a specific time of day as
being harder than another in adherence to medication
(morning versus evening dose). Of these, 6 stated that the
morning was more difficult due to waking up late and miss-
ing the regular time, rushing to school or work, or lack of food
early in the morning. The one set who reported that evenings
were more difficult cited lack of assistance and forgetting
during this time of the day.
Discussion
Our study conducted at a public HIV clinic in Kinshasa,
DRC suggests the complex nature of pediatric ART adher-
ence in a resource limited setting and its connection to psy-
chosocial, structural, and environmental variables. Most
prominent in relation to ART adherence were the dynamics
of the child–caregiver relationship, the importance of a
supportive structure for both the child and caregiver, and
HIV disclosure status of the child. Our results add to the
knowledge generated by other qualitative studies assessing
pediatric adherence in resource limited settings in that
psychosocial support structures and the HIV disclosure
status of the child play a prominent role with regards to ART
adherence.12,14,15,22 Our study is unique in that we evaluated
adherence-related perceptions and experiences among both
children and their respective caregivers. We found there was
considerable synchrony in the responses of each child–
caregiver set regarding their experiences with adherence,
although they may recall these experiences differently or
interpret barriers and facilitators to adherence in different
ways. Furthermore, the child–caregiver relationship and
nutritional support were both well-characterized and pro-
minent themes that emerged as important factors affecting
ART adherence.
The child–caregiver relationship is an important feature
related to adherence and is characterized in this study by the
reported relation of caregiver assistance, or lack thereof, to
adherence. In addition, the child–caregiver relationship and
its relation to adherence is illustrated by the emergent
themes of deception and conflict between the child and
caregiver. Our findings underscore the need to support
the caregiver and their child to work together to form a
strong relationship to promote adherence through trust and
understanding.
The children and caregivers in this study expressed a
considerable degree of frustration in dealing with HIV/
AIDS and with long-term medication. Only 25% of caregiv-
ers were biological parents. In sub-Saharan Africa alone,
over 14 million children are estimated to have lost one or
both parents to HIV/AIDS.23 Orphaned children may have
more strained relationships with nonparental caregivers
with whom they have had less time to form relationships
with. The ability to cope well with HIV may be a strong
correlate to adherence, which underscores the importance of
psychosocial well-being and support structures in place for
children with HIV.17,22,24
A paucity of food in the home or lack of resources to pro-
cure food has been cited as a potential barrier to adherence in
other qualitative studies, though it has not been well charac-
terized.14,25 In this study, the role of food and nutritional
support was very prominent, arising in more than half of all
interviews. Lack of nutritional support was cited by both
children and caregivers in a number of explored instances of
missed doses. Poor ART adherence combined with inade-
quate nutritional support may have a synergistically negative
effect on outcomes of children with HIV and may be further
explored. HIV care and treatment programs need adequate
resources to provide nutritional support for their patients. In a
country where undernutrition is rampant funding agencies
should not forget nutritional support for people on ART, es-
pecially children.25
Having routine practices or specific strategies in facilitating
adherence was important. A number of suggestions appeared
in other studies, including the use of timers, alarms, or cell
phones.3,25 Our study suggests that strategies as simple as
placing medications in a prominent place, associating medi-
cation taking with specific times of the day, specific activities,
or environmental cues may be extremely useful. In resource
limited settings where use of alarms, cell phones, or other
electronics may be uncommon or unavailable, culturally and
financially appropriate strategies should be used. A robust
child-caregiver relationship, including caregiver assistance
and minimizing conflict, may be necessary to develop team-
work needed for such strategies.
Participants perceived that a great deal of stigma was
associated with HIV/AIDS and with the taking of medica-
tions in their communities. When looking at the overall
spectrum of interviews, it was clear that the secretive nature
that surrounded taking medications often led to missed
doses in the setting of unavailable privacy. The need to
maintain privacy from other family members and from the
community at large with taking medications was expressed
to be a salient issue that pervaded daily life for these families.
The lack of a private place to store medicines as well as re-
liable private place to take medications was a common
practical factor associated with missed doses. Stigma also
related to the lack of HIV status disclosure, which also ap-
peared related to barriers of adherence. This was cited by
Table 3. Reported Adherence Experiences





Yesterday 8 40.0% Yesterday 1 5.0%
2 days ago 1 5.0% 2 days ago 1 5.0%
3 days ago 1 5.0% 3 days ago 1 5.0%
Any in last week 3 15.0% Any in last week 2 10.0%
Any in last month 1 5.0% Any in last month 4 20.0%
None missed 5 25.0% None missed 9 45.0%
Don’t know 0 0.0% Don’t know 1 5.0%
Not asked 1 5.0% Not asked 1 5.0%
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adults to justify withholding knowledge of HIV status to the
children, who felt by withholding this information they
would protect the child and reduce the risk that children
themselves may unwittingly disclose their status to other
family or community members.
Children being uninformed of their HIV infection was a
prominent aspect related to adherence in this study. Our re-
search results show that disclosed and non-disclosed children
viewed taking their medicine differently, as supported else-
where.21 Overall, status disclosed children and their caregiv-
ers expressed less frustration because knowledge of HIV
status was a motivational factor aiding adherence. Increased
understanding of the purpose of medications led to a greater
willingness to increase efforts to maintain adherence on the
part of the child.
In this study, frustration was a more prominent theme
with children unaware of their HIV status. There were also
more instances of deception and conflict arising with these
caregivers. Deception and conflict may breed mistrust and
could be a marker for poor child–caregiver relationships.
Given that a strong relationship and caregiver assistance
were cited in helping to maintain good adherence in this
study, poorer child–caregiver relationships with non-
disclosed children may help guide our understanding of
why disclosure status has been associated with poor adher-
ence in previous studies.14,21
We found that the caregivers and children brought up
many of the same issues, however characterized them dif-
ferently. For instance, as noted above, lack of food was
prominently featured as a potential barrier to adherence.
While children focused on the burning sensation they
experienced when taking ART on an empty stomach, adults
centered on the difficulty of providing increased quantities of
food. Furthermore, both expressed strong frustration with the
lack of assistance to cope with the illness and medications. It
was apparent that children needed more tangible assistance
when they talked about how they missed their doses. How-
ever, children often characterized this as a lack of assistance
coming directly from the primary caregiver rather than from a
group of caregivers. Adults on the other hand expressed
disappointment or frustration that no other adults or com-
munity members were available to help them and to share the
responsibility of caring for the child and their illness.
The differences in perception of adherence experiences
between children and adults may be important for future
studies and interventions to take into account, as survey data
or quantitative methodology may oversimplify an issue,
such as a lack of food, or fail to recognize that there may be
varying perspectives relating to a particular issue. In addi-
tion, it may be easy to identify barriers or facilitators, but
understanding how children and caregivers perceive and
experience these barriers differently will be important
for targeted interventions. Children and their caregivers
may each require uniquely directed strategies for improved
adherence.3
Despite children and caregivers characterizing some
themes differently, our findings reveal devoted caregivers are
very much in tune with the needs of their respective children
and ways to optimize child behavior given that similar
themes arose among the child-caregiver sets. This suggests
they play an equally important role as children when study-
ing adherence to pediatric regimens.
We made an attempt to characterize actual adherence ex-
periences among our study participants by directly asking
about their most recent missed dose, prefaced by a short script
to destigmatize missing doses. Unlike in our routine care
assessments, children and their caregivers acknowledged
missing doses, demonstrating the advantage of qualitative
research. Child and caregiver responses differed regarding
timing of the last missed dose. Caregivers overall estimated
lower occurrences of missed doses than their child counter-
parts. This may have been due to several reasons. For in-
stance, children may deceive their caregivers about taking
their medication. Despite our attempt to destigmatize non-
adherence before asking directly about adherence experi-
ences, social desirability bias may have been more prominent
among adults resulting in more favorable adherence report-
ing. Other studies have suggested that assessment of adher-
ence by directly asking subjects yields variable results and call
for more objective measures such as pill counts or electronic
monitoring.12,27–29
Our study has limitations. First, we interviewed mostly
children who had a suspected history of poor adherence. This
was helpful in understanding barriers to adherence, but we
might have missed children who could provide further in-
formation regarding facilitators or strategies toward im-
proving adherence. Although we attempted to characterize
the child’s relationship to the caregiver and interview the
person who played the most significant role in assisting with
ART, it was clear that each relationship varied and the length
of some relationships with nonparental caregivers was un-
known. Qualitative studies typically include a small number
of participants and findings are not meant to be generalizable.
They can, as shown here, provide valuable insights into the
issues and context and identify areas for continued quantita-
tive study and/or intervention.
It is clear pediatric adherence to ART in resource limited
settings is a complex process and HIV-positive children
and their caregivers face many challenges. Full under-
standing of this issue goes beyond the child–caregiver
dynamic. Intertwined with adherence are relationships
with the rest of the family group, the community, and with
the health care structure and support systems in place.15
Despite this, improving and sustaining pediatric ART
adherence will rely heavily on a robust child–caregiver
relationship and marks a highly feasible area for intervention
and continued study.
Our study results further underscore the need for increased
facilitation of HIV status disclosure to children in a supportive
environment and comprehensive care programs which focus
on improving support for both the child and caregiver. Psy-
chosocial support structures for children and caregivers
should be in place at facilities treating children with HIV and
providing ART. This should include counseling and educa-
tional services, as well as support from the health care system
in terms of nutritional support, devices that may assist with
adherence, such as a cell phone or alarm clock, or other ma-
terial goods. Reliable adherence measures are needed that can
be easily implemented to monitor and intervene on subopti-
mal adherence. Continued in-depth qualitative analysis will
be helpful in determining future quantitative studies and
determining how to structure targeted interventions toward
improving adherence.12 With continued scale-up up of ART
to children in sub-Saharan Africa and other resource limited
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settings, understanding and optimizing adherence must re-
main a high priority.
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